The global market for tardive dyskinesia treatment is experiencing significant growth. This trend is stimulated by a increasing prevalence of tardive dyskinesia, coupled with advances in treatment therapies. The market is segmented by various elements, including drug types, distribution channels, and geographic regions. Key players in the scene are